CVS Health Corp vs NRG Energy Inc — how do they compare? CVS Health Corp trades at $86.62 (market cap $112.49B), while NRG Energy Inc trades at $106.74 (market cap $22.83B). The key difference: CVS Health Corp is far larger — about 4.9× NRG Energy Inc's market cap, and CVS Health Corp pays the higher dividend (3.02%). Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and NRG Energy Inc for 62 Days on average.
| CVS | NRG | |
|---|---|---|
Market Cap | $112.49B | $22.83B |
Volume | 8,467,392 | 5,365,870 |
Sector | Health | Utilities |
52-Week High | $110.60 | $184.03 |
52-Week Low | $70.08 | $95.23 |
Typical Hold Time | 83 Days | 62 Days |
Enterprise Value | $174.83B | $46.79B |
Dividend Yield | 3.02% | 1.75% |
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.80, up 1.59% today, with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 27% upside. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $2.58 surpassing the $1.87 estimate. Revenue growth remains solid, reaching $402.07B in 2025, though net margins compressed to 1.18%. The technical picture shows bullish momentum with current price near key support at $87.
CVS presents a compelling value opportunity with attractive valuation multiples (P/E 23.21, P/S 0.27) and dividend stability, but faces margin pressure from healthcare cost trends. The stock's upside depends on maintaining earnings momentum amid reimbursement challenges and regulatory scrutiny highlighted in recent legal investigations.
NRG Energy trades at $106.32, up 2.63% today, with a bullish technical outlook supported by moving averages and ADX indicators. The company reported mixed Q2 2026 earnings with two consecutive misses but maintains strong analyst support (70% buy ratings) and a consensus price target of $202.90. Recent developments include a 1.2 GW Texas data center power project and a dividend payment scheduled for August 2026.
NRG presents growth potential through strategic investments in data center infrastructure and customer-backed power projects, though elevated debt levels and recent earnings volatility pose risks. The stock trades at reasonable valuation multiples (P/E 28.28, P/S 0.66) with strong profitability metrics (ROE 26.77%), but investors should monitor execution on new projects and debt management.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →NRG Energy is one of the largest retail energy providers in the U.S., with 7 million customers, including its 2021 acquisition of Direct Energy. It also is one of the largest U.S. independent power producers, with 16 gigawatts of nuclear, coal, gas, and oil power generation capacity primarily in Texas. Since 2018, NRG has divested its 47% stake in NRG Yield, among other renewable energy and conventional generation investments. NRG exited Chapter 11 bankruptcy as a stand-alone entity in December 2003.
Read more on NRG →